RIGI and viral infectious disease: It has been suggested that carvacrol may regulate excessive secretion of inflammatory factors via inhibiting both TLR and RIG-I signaling pathways which were activated under influenza virus infection so as to reduce lung damage resulting from viral infection (Zheng et al., 2021).